<DOC>
	<DOC>NCT00977769</DOC>
	<brief_summary>A randomized double-blind trial of oxytocin 5 u, carbetocin 100 Âµg and placebo with hemodynamic response as a primary outcome measure.</brief_summary>
	<brief_title>Carbetocin Versus Oxytocin and Hemodynamic Effects</brief_title>
	<detailed_description>Healthy pregnant women sheduled for elective cesarean section. Invasive hemodynmaic monitoring with LiDCO Plus.</detailed_description>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Healthy pregnant women for planned cesarean section Bleeding disorders Placenta disorders</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>cesarean delivery</keyword>
	<keyword>blood pressure</keyword>
	<keyword>cardiac output</keyword>
</DOC>